---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-001712"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T11:43:26.253654+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics appoints Juan Graham as CFO; Jonathan Hunt remains CAO

## Summary
- Juan Graham appointed CFO effective Jan 6, 2025; Jonathan Hunt steps down as CFO but stays CAO.
- Graham brings 25 years experience; previously CFO of FibroGen, finance leadership at Johnson & Johnson.
- Annual base salary $500k, target bonus 40%, signing bonus $80k, option grant of 400k shares with 4-year vest.
- Severance: 12 months salary plus pro-rated bonus and COBRA upon termination without cause or for good reason.
- Change of control: accelerated vesting of equity; severance of 12 months salary if not retained or termination within 12 months.

## SEC filing metadata
- accession: 0000950170-25-001712
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/catx-20250102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-001712
- JSON: https://secwatch.observer/filing/0000950170-25-001712.json
- Plain text: https://secwatch.observer/filing/0000950170-25-001712.txt

## Key facts
- Executive change
  Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..
  - Action: will no longer serve
  - Role: Chief Financial Officer
  source text: As of the Effective Date, Mr. Jonathan Hunt will no longer serve as the Company’s Chief Financial Officer but will remain in his role as the Company’s Chief Accounting Officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm
- Executive change
  Juan Graham was appointed as Chief Financial Officer at Perspective Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On January 2, 2025, the Board of Directors (the “Board”) of Perspective Therapeutics, Inc. (the “Company”) appointed Mr. Juan Graham as the Company’s Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.